Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

400
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
400
Subviral Agents01:29

Subviral Agents

41
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
41

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GC-MS-Based Comparative Analysis of Compounds in Host Plants and Insect Gut Extracts.

Metabolites·2026
Same author

Effects of CMV on T and NK Cells; With Emphasis on Immunometabolism.

BioMed research international·2026
Same author

Plant Viral Vectors for Vaccine Development.

Vaccines·2026
Same author

CRISPR-Cas9 editing of agricultural crops and medicinal plants: toward a cornucopia of natural products.

Critical reviews in biochemistry and molecular biology·2025
Same author

Editorial: Social aspects of crop genome editing.

Frontiers in genome editing·2025
Same author

Nano-icilin-driven TRPM8 activation elicits immunogenic exosomes with antitumor effects.

Nanomedicine (London, England)·2025
Same journal

Correction: Fukushima et al. Long-Term Immunogenicity of Rabies Pre-Exposure Prophylaxis in Japanese Adult Travelers: Comparison of Dosing Regimens. <i>Vaccines</i> 2025, <i>13</i>, 1169.

Vaccines·2026
Same journal

Access to Vaccines Among Asylum Seekers, Refugees, and Undocumented Migrants Across the Migratory Cycle in the European Union, European Economic Area, Switzerland and the United Kingdom: A Scoping Review.

Vaccines·2026
Same journal

Advances in Detection Methods for Human Respiratory Syncytial Virus Neutralizing Antibodies.

Vaccines·2026
Same journal

Insights from 25 Years of Measles and Measles-Rubella Vaccination Campaigns in the WHO African Region (2001-2025).

Vaccines·2026
Same journal

Post-Marketing Safety Surveillance of Influenza Vaccines in Anhui Province, China, 2016-2025.

Vaccines·2026
Same journal

Characteristics of Hypotonic-Hyporesponsive Episodes (HHEs) Following Childhood Vaccination: A 13-Year Analysis of Spontaneous Reports to the Dutch Pharmacovigilance Centre Lareb.

Vaccines·2026
See all related articles

Related Experiment Video

Updated: Jul 18, 2025

Viral Nanoparticles for In vivo Tumor Imaging
14:04

Viral Nanoparticles for In vivo Tumor Imaging

Published on: November 16, 2012

17.3K

Plant Virus Nanoparticles Combat Cancer.

Mehdi Shahgolzari1, Srividhya Venkataraman2, Anne Osano3

  • 1Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz 5166616471, Iran.

Vaccines
|August 26, 2023
PubMed
Summary
This summary is machine-generated.

Plant virus nanoparticles (PVNPs) offer a versatile nanotechnology for cancer treatment. These biocompatible nanoparticles can deliver drugs and stimulate immune responses against tumors.

Keywords:
deliverynanoparticlesplant virus-like particlesvaccines

More Related Videos

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors
11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

11.1K
Evaluation of Nanoparticle Uptake in Tumors in Real Time Using Intravital Imaging
08:04

Evaluation of Nanoparticle Uptake in Tumors in Real Time Using Intravital Imaging

Published on: June 21, 2011

18.4K

Related Experiment Videos

Last Updated: Jul 18, 2025

Viral Nanoparticles for In vivo Tumor Imaging
14:04

Viral Nanoparticles for In vivo Tumor Imaging

Published on: November 16, 2012

17.3K
Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors
11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

11.1K
Evaluation of Nanoparticle Uptake in Tumors in Real Time Using Intravital Imaging
08:04

Evaluation of Nanoparticle Uptake in Tumors in Real Time Using Intravital Imaging

Published on: June 21, 2011

18.4K

Area of Science:

  • Nanotechnology
  • Oncology
  • Biomedical Engineering

Background:

  • Plant virus nanoparticles (PVNPs) are emerging as a promising nanotechnology for cancer therapy.
  • Their inherent biocompatibility, stability, and customizable surface properties make them attractive for biomedical applications.

Purpose of the Study:

  • To explore the potential of PVNPs as a versatile platform for cancer treatment and imaging.
  • To highlight the capabilities of PVNPs in targeted drug delivery and immunotherapy.

Main Methods:

  • Engineering PVNPs for the encapsulation and targeted delivery of therapeutic agents (chemotherapy drugs, siRNA, immunomodulators).
  • Functionalizing PVNPs with targeting ligands for specific binding to cancer cell receptors.
  • Modifying PVNPs to express tumor-associated antigens for enhanced immunogenicity.

Main Results:

  • PVNPs demonstrate significant potential for targeted delivery of therapeutics to the tumor microenvironment (TME).
  • Surface functionalization allows for selective targeting of cancer cells, minimizing off-target effects.
  • Engineered PVNPs can elicit anti-tumor immune responses by presenting tumor-associated antigens.

Conclusions:

  • PVNPs represent a highly versatile platform with immense potential in combating cancer.
  • Further research is crucial to fully realize the clinical applications of PVNPs in oncology.